Advertisement

Neurochemical Research

, Volume 31, Issue 10, pp 1239–1246 | Cite as

The Increase of Choline Acetyltransferase Activity by Docosahexaenoic Acid in NG108-15 Cells Grown in Serum-free Medium is Independent of its Effect on Cell Growth

  • Eva Machová
  • Barbora Málková
  • Věra Lisá
  • Jana Nováková
  • Vladimír Doležal
Original Paper

Abstract

We investigated the influence of the polyunsaturated docosahexaenoic acid (22:6n-3; DHA) on the constitutive expression of choline acetyltransferase (ChAT) in native and induced expression in differentiated cholinergic cells NG108-15 grown in serum-free medium. Elimination of serum-derived trophic support resulted in growth arrest and a strong decrease of ChAT activity. In either conditions, DHA largely rescued general indicators of cell growth and function, and partially prevented the decrease of ChAT activity. However, the maximal effect on general cell state in native and differentiated cells, and ChAT activity in native cells, was reached at or below 10 μmol/l of DHA. In contrast, maximal induction of ChAT activity in differentiated cells required about six times higher concentrations of DHA. These data thus demonstrate stimulatory effect of DHA on ChAT activity that is independent of its general cell protective properties.

Keywords

Cholinergic neuron Docosahexaenoic acid Trophic support Cell growth Choline acetyltransferase Alzheimer’s disease Calcium influx Oxidative load α-Secretase Caspase-3 Cholesterol 

Notes

Acknowledgments

This study was enabled by Research project AV0Z 5011922 supported by EU project QLK1-CT-2002-00172 and grants IAA5011206 and LC554.

References

  1. 1.
    Bazan NG (2003) Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 44:2221–2233PubMedCrossRefGoogle Scholar
  2. 2.
    Jump DB (2002) The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 277:8755–8758PubMedCrossRefGoogle Scholar
  3. 3.
    Mucke L, Pitas RE (2004) Food for thought: essential fatty acid protects against neuronal deficits in transgenic mouse model of AD. Neuron 43:596–599PubMedGoogle Scholar
  4. 4.
    Ruxton CH, Reed SC, Simpson MJ, Millington KJ (2004) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 17:449–459PubMedCrossRefGoogle Scholar
  5. 5.
    Conner JM, Darracq MA, Roberts J, Tuszynski MH (2001) Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA 98:1941–1946PubMedCrossRefGoogle Scholar
  6. 6.
    Moriguchi T, Salem N (2003) Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 87:297–309PubMedCrossRefGoogle Scholar
  7. 7.
    Favreliere S, Perault MC, Huguet F, De Javel D, Bertrand N, Piriou A, Durand G (2003) DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging 24:233–243PubMedCrossRefGoogle Scholar
  8. 8.
    Hogyes E, Nyakas C, Kiliaan A, Farkas T, Penke B, Luiten PG (2003) Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 119:999–1012PubMedCrossRefGoogle Scholar
  9. 9.
    Hamprecht B (1977) Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma–glioma cell hybrids in cell culture. Int Rev Cytol 49:99–170PubMedCrossRefGoogle Scholar
  10. 10.
    Hamprecht B, Glaser T, Reiser G, Bayer E, Propst F (1985) Culture and characteristics of hormone-responsive neuroblastoma × glioma hybrid cells. Methods Enzymol 109:316–341PubMedGoogle Scholar
  11. 11.
    Erickson JD, Varoqui H, Schafer MK, Modi W, Diebler MF, Weihe E, R and J, Eiden LE, Bonner TI, Usdin TB (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a ‘cholinergic’ gene locus. J Biol Chem 269:21929–21932PubMedGoogle Scholar
  12. 12.
    Castell X, Diebler MF, Tomasi M, Bigari C, De Gois S, Berrard S, Mallet J, Israel M, Dolezal V (2002) More than one way to toy with ChAT and VAChT. J Physiol Paris 96:61–72PubMedCrossRefGoogle Scholar
  13. 13.
    Dolezal V, Castell X, Tomasi M, Diebler MF (2001) Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT MRNAs but fail to increase VAChT protein. Brain Res Bull 54:363–373PubMedCrossRefGoogle Scholar
  14. 14.
    Dolezal V, Lisa V, Diebler MF, Kasparova J, Tucek S (2001) Differentiation of NG108-15 cells induced by the combined presence of DbcAMP and dexamethasone brings about the expression of N and P/Q types of calcium channels and the inhibitory influence of muscarinic receptors on calcium influx. Brain Res 910:134–141PubMedCrossRefGoogle Scholar
  15. 15.
    Novakova J, Mikasova L, Machova E, Lisa V, Dolezal V (2005) Chronic treatment with amyloid beta(1–42) inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling. Brain Res 1062:101–110PubMedCrossRefGoogle Scholar
  16. 16.
    Berrard S, Varoqui H, Cervini R, Israel M, Mallet J, Diebler MF (1995) Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J Neurochem 65:939–942PubMedCrossRefGoogle Scholar
  17. 17.
    Fonnum F (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115:465–472PubMedGoogle Scholar
  18. 18.
    Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356PubMedCrossRefGoogle Scholar
  19. 19.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  20. 20.
    Kasparova J, Lisa V, Tucek S, Dolezal V (2001) Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1–42)) abolishes calcium influx via N-type calcium channels. Neurochem Res 26:1079–1084PubMedCrossRefGoogle Scholar
  21. 21.
    Aid S, Vancassel S, Poumes-Ballihaut C, Chalon S, Guesnet P, Lavialle M (2003) Effect of a diet-induced N-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44:1545–1551PubMedCrossRefGoogle Scholar
  22. 22.
    Kim HY, Akbar M, Kim KY (2001) Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J Mol Neurosci 16:223–227 discussion 279–284PubMedCrossRefGoogle Scholar
  23. 23.
    Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Monma Y, Togashi H, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997) Effects of dietary docosahexaenoic acid on survival time and stroke-related behavior in stroke-prone spontaneously hypertensive rats. Gen Pharmacol 29:401–407PubMedGoogle Scholar
  24. 24.
    Tsukada H, Kakiuchi T, Fukumoto D, Nishiyama S, Koga K (2000) Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Brain Res 862:180–186PubMedCrossRefGoogle Scholar
  25. 25.
    Minami M, Kimura S, Endo T, Hamaue N, Hirafuji M, Togashi H, Matsumoto M, Yoshioka M, Saito H, Watanabe S, Kobayashi T, Okuyama H (1997) Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 58:1123–1129PubMedCrossRefGoogle Scholar
  26. 26.
    Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–414PubMedCrossRefGoogle Scholar
  27. 27.
    Dolezal V, Kasparova J (2003) Beta-amyloid and cholinergic neurons. Neurochem Res 28:499–506PubMedCrossRefGoogle Scholar
  28. 28.
    Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137–147PubMedCrossRefGoogle Scholar
  29. 29.
    Blusztajn JK, Berse B (2000) The cholinergic neuronal phenotype in Alzheimer’s disease. Metab Brain Dis 15:45–64PubMedCrossRefGoogle Scholar
  30. 30.
    Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci USA 97:6826–6831PubMedCrossRefGoogle Scholar
  31. 31.
    Chen KS, Nishimura MC, Armanini MP, Crowley C, Spencer SD, Phillips HS (1997) Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits. J Neurosci 17:7288–7296PubMedGoogle Scholar
  32. 32.
    Granholm AC, Sanders LA, Crnic LS (2000) Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down’s syndrome. Exp Neurol 161:647–663PubMedCrossRefGoogle Scholar
  33. 33.
    Isacson O, Seo H, Lin L, Albeck D, Granholm AC (2002) Alzheimer’s disease and Down’s syndrome: roles of APP, trophic factors and ACh. Trends Neurosci 25:79–84PubMedCrossRefGoogle Scholar
  34. 34.
    Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, Berardi N, Cattaneo A (2000) Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20:2589–2601PubMedGoogle Scholar
  35. 35.
    Smith DE, Roberts J, Gage FH, Tuszynski MH (1999) Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA 96:10893–10898PubMedCrossRefGoogle Scholar
  36. 36.
    Aid S, Vancassel S, Linard A, Lavialle M, Guesnet P (2005) Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 135:1008–1013PubMedGoogle Scholar
  37. 37.
    Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39PubMedCrossRefGoogle Scholar
  38. 38.
    Fan QW, Yu W, Gong JS, Zou K, Sawamura N, Senda T, Yanagisawa K, Michikawa M (2002) Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. J Neurochem 80:178–190PubMedCrossRefGoogle Scholar
  39. 39.
    Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer’s disease: the cholesterol connection. Nat Neurosci 6:345–351PubMedCrossRefGoogle Scholar
  40. 40.
    Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, Strooper BD, Muller U, Shen J, Hartmann T (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 11:1045–1047Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Eva Machová
    • 1
  • Barbora Málková
    • 1
  • Věra Lisá
    • 1
  • Jana Nováková
    • 1
  • Vladimír Doležal
    • 1
  1. 1.Institute of Physiology CASPrague 4Czech Republic

Personalised recommendations